1. Furukawa, T., Fu, X., Kubota, T., Watanabe, M.,
Kitajima, M., and Hoffman, R.M. Nude mouse metastatic models of human
stomach cancer constructed using orthotopic implantation of
histologically intact tissue. Cancer Res. 53, 1204-1208, 1993.
2. Furukawa, T., Kubota, T., Watanabe, M., Kitajima, M., and Hoffman,
R.M. Orthotopic transplantation of histologically intact clinical
specimens of stomach cancer to nude mice: Correlation of metastatic
sites in mouse and individual patient donors. Int. J. Cancer 53,
608-612, 1993.
3. Furukawa, T., Kubota, T., Watanabe, M., Kitajima, M., and Hoffman,
R.M. Differential chemosensitivity of local and metastatic human gastric
cancer after orthotopic transplantation of histologically intact tumor
tissue in nude mice. Int. J. Cancer 54, 397-401, 1993.
4. Inada, T., Ichikawa, A., Kubota, T., Ogata, Y., Moossa, A.R., and
Hoffman, R.M. 5-FU-induced apoptosis correlates with efficacy against
human gastric and colon cancer xenografts in nude mice. Anticancer Res.
17, 1965-1972, 1997.
5. Hasegawa, S., Yang, M., Chishima, T., Shimada, H., Moossa, A.R.,
Hoffman, R.M. In vivo tumor delivery of the green fluorescent protein
gene to report future occurrence of metastasis. Cancer Gene Therapy 7,
1336-1340, 2000.
6. Kamiyama,
M., Ichikawa, Y., Ishikawa, T., Chishima, T., Hasegawa, S., Hamaguchi,
Y., Nagashima, Y., Miyagi, Y., Mitsuhashi, M., Hyndman, D., Hoffman, R.M.,
Ohki, S., and Shimada, H. VEGF
receptor antisense therapy inhibits angiogenesis and peritoneal
dissemination of human gastric cancer in nude mice. Cancer Gene Therapy 9,
197-201, 2002.
